Latest
News

  • Welcome Matt  

    No, not the kind you wipe your shoes on, our Matt is the latest

  • How much does Rett syndrome cost? 

    Reverse Rett was recently given a pro bono grant from health economics and rare

  • London Gala – don’t leave it any longer! 

    Everyone at Reverse Rett is looking forward to seeing you at this year’s London

  • A new face at Reverse Rett 

    This month, we’ve been pleased to welcome Sarah Gubbins to our small team. Sarah

  • First UK Rett syndrome gene therapy trial site open 

    Today, the first UK Rett syndrome gene therapy clinical trial site has officially opened.

  • Update from Taysha Gene Therapies

      Taysha Gene Therapies have provided an update on their Rett syndrome clinical trials

  • Join Our Mission: Senior Development Officer Role at Reverse Rett

    We are seeking an experienced Senior Development Officer to join Reverse Rett to help

  • Purple diamond logo with a sapling growing out of the tip
    Neurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

    On June 18th, Neurogene provided an update on the first “high dose” patient in

  • Taysha Announcement Key Takeaways

    On June 18th, Taysha shared interim clinical data from the REVEAL Adolescent & Adult

  • Purple diamond logo with a sapling growing out of the tip
    Neurogene press release: NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program

    On June 3rd, Neurogene announced that the FDA has chosen their Rett syndrome gene

  • Charities urged to check fundraisers’ credentials due to Pudsey scammer

    Charities have been in the news this week, due to the unscrupulous acts of

  • Taysha receives go-ahead for early dose escalation in adolescent and adult Rett syndrome gene therapy trial 

    Yesterday, 19th March 2024, Taysha Gene Therapies published a press release with an update